FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2735508711> ?p ?o ?g. }

• W2735508711 endingPage "60" @default.
• W2735508711 startingPage "53" @default.
• W2735508711 abstract "Abstract Aim To investigate the prevalence of hypoglycaemia during sulfonylurea (SU) treatment of type 2 diabetes mellitus (T2DM) in Greece and its influence on glycaemic control, treatment adherence and quality of life (QoL). Patients and methods This was a retrospective cross-sectional study. We included 383 T2DM patients ≥30 years old on treatment with SU in monotherapy or in combination with metformin for at least 6 months. Patients were requested to fill in retrospective questionnaires on hypoglycaemia experience, adherence, weight gain and lifestyle/behavioural factors along with QoL (EQ-5D-3L), treatment satisfaction (TSQM), and fear of hypoglycaemia (HFS-II Worry scale). Results HbA1c<7% was found in 161 (42.0%) patients. In total, 165 (43.1%) patients reported hypoglycaemic symptoms during the previous 6 months: 41.6% (67/161) of those with HbA1c <7% and 44.1% (98/222) of those with HbA1c ≥7%. Glycaemic control was achieved by 43.1% (94/218) of patients without hypoglycaemia and 50.0% (41/82), 36.8% (25/68) and 6.7% (1/15) of patients with mild, moderate or severe hypoglycaemia, respectively (p=0.013). In multivariate analysis, both occurrence (none vs. mild/moderate/severe) and severity (none vs. mild vs. moderate vs. severe) of hypoglycaemia were significantly associated with impaired global treatment satisfaction (p=0.002 and p<0.0001 respectively) and HFS-II Worry scale scores (both p<0.0001), while lower QoL (EQ-5D (UK) Index) was related to hypoglycaemia severity (p=0.024) only. Finally, treatment adherence was associated with increased (none/mild vs. moderate/severe) hypoglycaemia severity in univariate analysis (p=0.019). Conclusion A high prevalence of patient treated with SU reported hypoglycaemia in Greek healthcare settings with negative effects on treatment satisfaction, patient worry and adherence. Severity of hypoglycaemic symptoms was associated with reduced glycaemic control." @default.
• W2735508711 created "2017-07-21" @default.
• W2735508711 creator A5015324651 @default.
• W2735508711 creator A5018511783 @default.
• W2735508711 creator A5022866431 @default.
• W2735508711 creator A5034083330 @default.
• W2735508711 creator A5045794946 @default.
• W2735508711 creator A5057040348 @default.
• W2735508711 creator A5064490540 @default.
• W2735508711 creator A5074255638 @default.
• W2735508711 creator A5081272181 @default.
• W2735508711 creator A5086414107 @default.
• W2735508711 date "2017-07-13" @default.
• W2735508711 modified "2023-10-18" @default.
• W2735508711 title "The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece" @default.
• W2735508711 cites W1502077872 @default.
• W2735508711 cites W1526927233 @default.
• W2735508711 cites W1965510020 @default.
• W2735508711 cites W1983664900 @default.
• W2735508711 cites W2040028849 @default.
• W2735508711 cites W2047076943 @default.
• W2735508711 cites W2053804091 @default.
• W2735508711 cites W2059439623 @default.
• W2735508711 cites W2075086954 @default.
• W2735508711 cites W2079889285 @default.
• W2735508711 cites W2082173557 @default.
• W2735508711 cites W2100442612 @default.
• W2735508711 cites W2111876001 @default.
• W2735508711 cites W2118402327 @default.
• W2735508711 cites W2124234371 @default.
• W2735508711 cites W2136374260 @default.
• W2735508711 cites W2144317224 @default.
• W2735508711 cites W2146286204 @default.
• W2735508711 cites W2148754755 @default.
• W2735508711 cites W2154407827 @default.
• W2735508711 cites W2158312041 @default.
• W2735508711 cites W2159969745 @default.
• W2735508711 cites W2160088494 @default.
• W2735508711 cites W2163274652 @default.
• W2735508711 cites W2172193326 @default.
• W2735508711 cites W2218762394 @default.
• W2735508711 cites W2221706065 @default.
• W2735508711 cites W2337454357 @default.
• W2735508711 cites W2407625702 @default.
• W2735508711 cites W2439110852 @default.
• W2735508711 cites W2473786944 @default.
• W2735508711 cites W2528985868 @default.
• W2735508711 cites W2769264260 @default.
• W2735508711 doi "https://doi.org/10.1055/s-0043-109242" @default.
• W2735508711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28704857" @default.
• W2735508711 hasPublicationYear "2017" @default.
• W2735508711 type Work @default.
• W2735508711 sameAs 2735508711 @default.
• W2735508711 citedByCount "12" @default.
• W2735508711 countsByYear W27355087112019 @default.
• W2735508711 countsByYear W27355087112020 @default.
• W2735508711 countsByYear W27355087112021 @default.
• W2735508711 countsByYear W27355087112022 @default.
• W2735508711 countsByYear W27355087112023 @default.
• W2735508711 crossrefType "journal-article" @default.
• W2735508711 hasAuthorship W2735508711A5015324651 @default.
• W2735508711 hasAuthorship W2735508711A5018511783 @default.
• W2735508711 hasAuthorship W2735508711A5022866431 @default.
• W2735508711 hasAuthorship W2735508711A5034083330 @default.
• W2735508711 hasAuthorship W2735508711A5045794946 @default.
• W2735508711 hasAuthorship W2735508711A5057040348 @default.
• W2735508711 hasAuthorship W2735508711A5064490540 @default.
• W2735508711 hasAuthorship W2735508711A5074255638 @default.
• W2735508711 hasAuthorship W2735508711A5081272181 @default.
• W2735508711 hasAuthorship W2735508711A5086414107 @default.
• W2735508711 hasConcept C118552586 @default.
• W2735508711 hasConcept C126322002 @default.
• W2735508711 hasConcept C134018914 @default.
• W2735508711 hasConcept C159110408 @default.
• W2735508711 hasConcept C167135981 @default.
• W2735508711 hasConcept C2777180221 @default.
• W2735508711 hasConcept C2778854520 @default.
• W2735508711 hasConcept C2779306644 @default.
• W2735508711 hasConcept C2779951463 @default.
• W2735508711 hasConcept C2779978724 @default.
• W2735508711 hasConcept C2780323712 @default.
• W2735508711 hasConcept C2780668416 @default.
• W2735508711 hasConcept C2910068830 @default.
• W2735508711 hasConcept C38180746 @default.
• W2735508711 hasConcept C555293320 @default.
• W2735508711 hasConcept C558461103 @default.
• W2735508711 hasConcept C71924100 @default.
• W2735508711 hasConceptScore W2735508711C118552586 @default.
• W2735508711 hasConceptScore W2735508711C126322002 @default.
• W2735508711 hasConceptScore W2735508711C134018914 @default.
• W2735508711 hasConceptScore W2735508711C159110408 @default.
• W2735508711 hasConceptScore W2735508711C167135981 @default.
• W2735508711 hasConceptScore W2735508711C2777180221 @default.
• W2735508711 hasConceptScore W2735508711C2778854520 @default.
• W2735508711 hasConceptScore W2735508711C2779306644 @default.
• W2735508711 hasConceptScore W2735508711C2779951463 @default.
• W2735508711 hasConceptScore W2735508711C2779978724 @default.
• W2735508711 hasConceptScore W2735508711C2780323712 @default.

• next